KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

HCA Healthcare (HCA) Income from Non-Controlling Interests (2016 - 2025)

HCA Healthcare (HCA) has disclosed Income from Non-Controlling Interests for 16 consecutive years, with $238.0 million as the latest value for Q2 2025.

  • On a quarterly basis, Income from Non-Controlling Interests changed N/A to $238.0 million in Q2 2025 year-over-year; TTM through Jun 2025 was $876.0 million, a N/A change, with the full-year FY2025 number at $998.0 million, changed N/A from a year prior.
  • Income from Non-Controlling Interests was $238.0 million for Q2 2025 at HCA Healthcare, up from $215.0 million in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $565.0 million in Q4 2022 to a low of $157.0 million in Q1 2021.
  • A 5-year average of $231.7 million and a median of $211.0 million in 2024 define the central range for Income from Non-Controlling Interests.
  • Peak YoY movement for Income from Non-Controlling Interests: dropped 28.73% in 2021, then soared 195.81% in 2022.
  • HCA Healthcare's Income from Non-Controlling Interests stood at $191.0 million in 2021, then skyrocketed by 195.81% to $565.0 million in 2022, then crashed by 68.14% to $180.0 million in 2023, then rose by 17.78% to $212.0 million in 2024, then grew by 12.26% to $238.0 million in 2025.
  • Per Business Quant, the three most recent readings for HCA's Income from Non-Controlling Interests are $238.0 million (Q2 2025), $215.0 million (Q1 2025), and $212.0 million (Q3 2024).